Scott Requadt - Insider Trading & Ownership
-
Entity
-
Individual
-
Location
-
101 Main Street, Suite 1210, Cambridge, MA
-
Summary
-
The estimated net worth of Scott Requadt is at least $17.8M dollars as of March 28, 2024. Scott Requadt is the Former Chief Executive Officer of Talaris Therapeutics, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $17.5M. Scott Requadt is the Director of ESSA Pharma Inc. and owns shares of ESSA Pharma Inc. (EPIX) stock worth about $300K.
Ownership of Scott Requadt
Insider Transactions Reported by Scott Requadt:
* An asterisk sign (*) next to the price indicates that the price is likely invalid.